Cas no for 274693-27-5,(1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich

Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

274693-27-5

[CAS Name] (1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

[Formula] C23H28F2N6O4S

Search Products Post Sourcing Request

Basica Info

[CAS Name](1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
[Alias]Ticagrelor; AR-C126532; AZD6140; (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol
[Number]274693-27-5
[EINECS]
[Formula]C23H28F2N6O4S
[Molecular weight]522.568

274693-27-5 Suppliers

Company

Main Products

Rensin Chemicals Limited

Ticagrelor tablets are indicated to reduce the risk of cardiovascular death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel.

Ticagrelor tablets also reduce the risk of stent thrombosis in patients who have been stented for treatment of ACS

Send Inquiry

Jinan Lead Pharm-Chemical Co.,LTD

Send Inquiry

Zhuhai HRD Pharmaceutical Co., Ltd.

Ticagrelor1. HRD was founed in 2009, which has more than decades experience in Pharmaceutical industry; 2. HRD is a vertically integrated company for R&D, production and marketing; 3. We are stable supplying our intermediates&API to the global market and work with more than 20 countries'client; 4.Our new site is under construction currently, its design can meet the CGMP,EMA,USFDA standard for the international business, and it is expected to launch at the middle of 2022 for the API&Intermediates' production. We are very strong for the intermediates of Oseltamivir Phosphate,Orlistat,Fluvoxamine maleate，Edoxaban,Fimasartan,IIaprazole,Vonoprazan Fumarate, Tavaborele, Ticagrelor and so on.

Send Inquiry

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us: About PharmaSources; Terms of Service; Privacy Policy; Event Data Sharing Notice; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight January 2025

PharmaSources Customer Service